Market research reports, consulting: Global Market Insights Inc.

Home > Healthcare > Medical Devices > Diagnostic Devices > hematocrit test devices market

Hematocrit Test Devices Market Trends

Report ID: GMI12760 Published Date: December 2024Report Format: PDF
Download Free Sample
Summary
Table of Content

Hematocrit Test Devices Market Trends

The market is witnessing significant growth driven by advancements in non-invasive testing, surging need for integrated wearable health technology, and increased adoption of home care testing, among other factors are boosting the industry growth.

  • Further, there is a growing trend toward miniaturizing hematocrit testing devices, making them more portable and user-friendly. These compact devices allow for easier transport and use in various settings, including remote locations, fieldwork, and by non-specialized healthcare personnel.
  • Additionally, more hematocrit test devices are integrating with electronic health records (EHR) systems, allowing for seamless data sharing between healthcare providers. This trend enhances the continuity of care, streamlines patient management, and facilitates data-driven decision-making, thereby aforementioned factors are expected to drive the market.
Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :

How big is the hematocrit test devices market?+

The global hematocrit test devices industry was valued at USD 3.8 billion in 2024 and is projected to grow at a 4.4% CAGR from 2025 to 2034, driven by the increasing prevalence of blood disorders and advancements in point-of-care testing.

What is the revenue contribution of the instruments segment in the hematocrit test devices industry?+

The instruments segment generated USD 2.2 billion in revenue in 2024, supported by the consistent demand for reliable hematocrit testing in clinical and diagnostic settings.

How much is the U.S. hematocrit test devices industry worth?+

The U.S. hematocrit test devices market was valued at USD 1.4 billion in 2024 and is expected to grow at a 3.9% CAGR from 2025 to 2034, driven by the high prevalence of blood disorders requiring regular monitoring.

Who are some of the prominent players in the hematocrit test devices industry?+

Key players in the market include MENARINI Group, Abbott, BIO-RAD, Boule, Danaher, Diatron, EKF, Roche, HORIBA Medical, Mindray, NIHON KOHDEN, Nova Biomedical, SENSA CORE, SIEMENS Healthineers, and Sysmex.

Hematocrit Test Devices Market Scope

Related Reports

Buy Now

Buy Now

Premium Report Details

Download Free Sample